WallStreetZenWallStreetZen

NYSEMKT: PTHS
Pelthos Therapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
Pelthos Therapeutics revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PTHS annual revenue was $0.0, with N/A growth year-over-year.

PTHS revenue history

Current Revenue
$0.0
Current Earnings
-$7.4M
Current Profit Margin
0%

Be the first to know when PTHS announces revenue.

PTHS Revenue History By Year

PTHS Yearly RevenuePTHS RevenuePTHS ChangePTHS Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00-$199.93k-100.00%
2020-12-31$199.93kN/AN/A

1 of 1

Pelthos Therapeutics Revenue FAQ

What was PTHS's revenue last quarter?

Pelthos Therapeutics (NYSEMKT: PTHS) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Pelthos Therapeutics's revenue was $0.00.

What was Pelthos Therapeutics's revenue in 2024?

Pelthos Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Pelthos Therapeutics make in a day?

Based on Pelthos Therapeutics annual revenue for the past four years, PTHS makes an average of $0.00 per day.

What was Pelthos Therapeutics's annual revenue growth in the past year?

As of Q3 2025, Pelthos Therapeutics's revenue has grown null year over year. Pelthos Therapeutics's revenue in the past year totaled $0.00.

How much does Pelthos Therapeutics make in a year?

Pelthos Therapeutics's revenue by year for the past four years is:
  • Pelthos Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Pelthos Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Pelthos Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Pelthos Therapeutics's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.